Prelude Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-500
Closed -$24K 1973
2020
Q1
$24K Buy
+500
New +$26K ﹤0.01% 938
2019
Q4
Sell
-1,000
Closed -$47K 1940
2019
Q3
$47K Buy
+1,000
New +$45.6K ﹤0.01% 1179
2018
Q4
Sell
-1,500
Closed -$81K 1796
2018
Q3
$81K Sell
1,500
-33,400
-96% -$1.71M ﹤0.01% 1009
2018
Q2
$1.7M Buy
+34,900
New +$1.98M 0.11% 198

Other funds holding CAH

Prelude Capital Management's CAH Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Cardinal Health (CAH) in Q2 2026: 2,752 shares worth $654K. The stake represents 0.05% of the portfolio and ranks #422 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in CAH as recently as Q1 2025.

Prelude Capital Management first reported a position in CAH in Q3 2013 and has held it in 37 quarters since. The position peaked at $1.32M in Q3 2022. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Prelude Capital Management held 2,752 shares of Cardinal Health worth $654K as of Q2 2026.
  • Cardinal Health was a new Prelude Capital Management position in Q2 2026.
  • Cardinal Health made up 0.05% of Prelude Capital Management's portfolio in Q2 2026, its #422 holding.
  • Prelude Capital Management first reported a position in Cardinal Health in Q3 2013 and has held it in 37 quarters since.
  • Prelude Capital Management's Cardinal Health position peaked at $1.32M in Q3 2022.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.